Literature DB >> 19141612

Cyclic AMP-dependent protein kinase signaling modulates pregnane x receptor activity in a species-specific manner.

Kristin Lichti-Kaiser1, Chenshu Xu, Jeff L Staudinger.   

Abstract

Pregnane x receptor is a ligand-activated transcription factor that regulates drug-inducible expression of several key cytochrome P450 enzymes and drug transporter proteins in liver and intestine in a species-specific manner. Activation of this receptor modulates several key biochemical pathways, including gluconeogenesis, beta-oxidation of fatty acids, fatty acid uptake, cholesterol homeostasis, and lipogenesis. It is of current interest to determine whether the interaction between pregnane x receptor and these key biochemical pathways is evolutionarily conserved. We show here that activation of the cyclic AMP-dependent protein kinase signaling pathway synergizes with pregnane x receptor-mediated gene activation in mouse hepatocytes. Conversely, cyclic AMP-dependent protein kinase signaling has a repressive effect upon pregnane x receptor-mediated gene activation in rat and human hepatocytes. We show that the human pregnane x receptor protein can serve as an effective substrate for catalytically active cyclic AMP-dependent protein kinase in vitro. Metabolic labeling of the protein in vivo indicates that human pregnane x receptor exists as a phosphoprotein and that activation of cyclic AMP-dependent protein kinase signaling modulates the phosphorylation status of pregnane x receptor. Activation of cyclic AMP-dependent protein kinase signaling also modulates the interactions of pregnane x receptor with protein cofactors. Our results define the species-specific impact of cyclic AMP-dependent protein kinase signaling on pregnane x receptor and provide a molecular explanation of cyclic AMP-dependent protein kinase-mediated repression of human pregnane x receptor activity. Taken together, our results identify a novel mode of regulation of pregnane x receptor activity and highlight prominent functional differences in the process across species.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19141612      PMCID: PMC2652295          DOI: 10.1074/jbc.M807426200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Humanized xenobiotic response in mice expressing nuclear receptor SXR.

Authors:  W Xie; J L Barwick; M Downes; B Blumberg; C M Simon; M C Nelson; B A Neuschwander-Tetri; E M Brunt; P S Guzelian; R M Evans
Journal:  Nature       Date:  2000-07-27       Impact factor: 49.962

Review 2.  Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.

Authors:  Jeff L Staudinger; Kristin Lichti
Journal:  Mol Pharm       Date:  2007-12-27       Impact factor: 4.939

3.  Regulation of phenobarbital induction of the cytochrome P450 2b9/10 genes in primary mouse hepatocyte culture. Involvement of calcium- and cAMP-dependent pathways.

Authors:  N Marc; M Galisteo; D Lagadic-Gossmann; A Fautrel; F Joannard; A Guillouzo; L Corcos
Journal:  Eur J Biochem       Date:  2000-02

4.  The PREgnane X receptor gene-humanized mouse: a model for investigating drug-drug interactions mediated by cytochromes P450 3A.

Authors:  Xiaochao Ma; Yatrik Shah; Connie Cheung; Grace L Guo; Lionel Feigenbaum; Kristopher W Krausz; Jeffrey R Idle; Frank J Gonzalez
Journal:  Drug Metab Dispos       Date:  2006-11-08       Impact factor: 3.922

Review 5.  The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression.

Authors:  Sang K Kim; Raymond F Novak
Journal:  Pharmacol Ther       Date:  2006-11-13       Impact factor: 12.310

6.  A novel panel of mouse models to evaluate the role of human pregnane X receptor and constitutive androstane receptor in drug response.

Authors:  Nico Scheer; Jillian Ross; Anja Rode; Branko Zevnik; Sandra Niehaves; Nicole Faust; C Roland Wolf
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

7.  Cyclin-dependent kinase 2 negatively regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells.

Authors:  Wenwei Lin; Jing Wu; Hanqing Dong; David Bouck; Fu-Yue Zeng; Taosheng Chen
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

Review 8.  PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators.

Authors:  Frank J Gonzalez; Yatrik M Shah
Journal:  Toxicology       Date:  2007-10-07       Impact factor: 4.221

9.  The traditional Chinese herbal remedy tian xian activates pregnane X receptor and induces CYP3A gene expression in hepatocytes.

Authors:  Kristin Lichti-Kaiser; Jeff L Staudinger
Journal:  Drug Metab Dispos       Date:  2008-05-12       Impact factor: 3.922

10.  Human nuclear pregnane X receptor cross-talk with CREB to repress cAMP activation of the glucose-6-phosphatase gene.

Authors:  Susumu Kodama; Rick Moore; Yukio Yamamoto; Masahiko Negishi
Journal:  Biochem J       Date:  2007-11-01       Impact factor: 3.857

View more
  25 in total

1.  Protein phosphatase 2Cbetal regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells.

Authors:  Satyanarayana R Pondugula; Alexander A Tong; Jing Wu; Jimmy Cui; Taosheng Chen
Journal:  Drug Metab Dispos       Date:  2010-06-10       Impact factor: 3.922

Review 2.  Sulfotransferase genes: regulation by nuclear receptors in response to xeno/endo-biotics.

Authors:  Susumu Kodama; Masahiko Negishi
Journal:  Drug Metab Rev       Date:  2013-09-11       Impact factor: 4.518

3.  Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation.

Authors:  J P Hernandez; L C Mota; W S Baldwin
Journal:  Curr Pharmacogenomics Person Med       Date:  2009-06-01

Review 4.  Pregnane X receptor- and CYP3A4-humanized mouse models and their applications.

Authors:  Jie Cheng; Xiaochao Ma; Frank J Gonzalez
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

5.  SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes.

Authors:  Wenqi Cui; Mengxi Sun; Nadezhda Galeva; Todd D Williams; Yoshiaki Azuma; Jeff L Staudinger
Journal:  Drug Metab Dispos       Date:  2015-06-10       Impact factor: 3.922

Review 6.  Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic response.

Authors:  Satyanarayana R Pondugula; Sridhar Mani
Journal:  Cancer Lett       Date:  2012-08-29       Impact factor: 8.679

7.  Role of c-Jun-N-Terminal Kinase in Pregnane X Receptor-Mediated Induction of Human Cytochrome P4503A4 In Vitro.

Authors:  Guncha Taneja; Chun Chu; Paramahamsa Maturu; Bhagavatula Moorthy; Romi Ghose
Journal:  Drug Metab Dispos       Date:  2018-02-12       Impact factor: 3.922

Review 8.  Post-translational and post-transcriptional modifications of pregnane X receptor (PXR) in regulation of the cytochrome P450 superfamily.

Authors:  Tomas Smutny; Sridhar Mani; Petr Pavek
Journal:  Curr Drug Metab       Date:  2013-12       Impact factor: 3.731

Review 9.  PXR: More Than Just a Master Xenobiotic Receptor.

Authors:  Peter O Oladimeji; Taosheng Chen
Journal:  Mol Pharmacol       Date:  2017-11-07       Impact factor: 4.436

10.  A systematic analysis of predicted phosphorylation sites within the human pregnane X receptor protein.

Authors:  Kristin Lichti-Kaiser; Dan Brobst; Chenshu Xu; Jeff L Staudinger
Journal:  J Pharmacol Exp Ther       Date:  2009-07-17       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.